Stakeholders in health research and policymakers will discuss:
Priorities for regulation and the role of the MHRA;
Meeting the challenge of regulating and developing medicines during the Covid-19 Pandemic;
Stakeholder priorities for medicine regulation - safety, research integrity and innovation:
The future for collaboration with the EU, and the UK’s relationship with the EMA ;
Using technology to tackle irresponsible medical ads - partnership with online platforms and statutory enforcement partners; and
Key issues for ensuring quality in clinical trials and the medicine approval process - research integrity, public trust and workforce development.
London, UK (online)
Ask for a Free trial and get access to the latest stories
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
an initial 10 day temporary access of APM Health Europe.